Information Journal Paper
APA:
CopyTAKAYAMA, T., Sugihara, T., KAMEDA, T., YAMAZAKI, M., Komatsubara, M., KAMEI, J., Fujisaki, A., ANDO, S., & FUJIMURA, T.. (2022). Treatment outcome of radium-223 treatment for castration-resistant prostate cancer and bone metastases at a single university hospital. INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 20(1), 75-81. SID. https://sid.ir/paper/989502/en
Vancouver:
CopyTAKAYAMA T., Sugihara T., KAMEDA T., YAMAZAKI M., Komatsubara M., KAMEI J., Fujisaki A., ANDO S., FUJIMURA T.. Treatment outcome of radium-223 treatment for castration-resistant prostate cancer and bone metastases at a single university hospital. INTERNATIONAL JOURNAL OF RADIATION RESEARCH[Internet]. 2022;20(1):75-81. Available from: https://sid.ir/paper/989502/en
IEEE:
CopyT. TAKAYAMA, T. Sugihara, T. KAMEDA, M. YAMAZAKI, M. Komatsubara, J. KAMEI, A. Fujisaki, S. ANDO, and T. FUJIMURA, “Treatment outcome of radium-223 treatment for castration-resistant prostate cancer and bone metastases at a single university hospital,” INTERNATIONAL JOURNAL OF RADIATION RESEARCH, vol. 20, no. 1, pp. 75–81, 2022, [Online]. Available: https://sid.ir/paper/989502/en